Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...
Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...
Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...
New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.
Statewide Practice Enrolling Patients in Global, Late-Phase Clinical Trial ...
SGLT2 inhibitor use was associated with a significantly lower risk for androgen deprivation therapy (ADT) failure and next-generation hormonal agent failure in men with prostate cancer. SGLT2 ...
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently ...
A new legislative push to make ivermectin available without a prescription in Wyoming is drawing sharp criticism from medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results